SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Aspira Women's Health Inc. (AWH) .
本页证实的标准:
- VALUE (100/100, 通过) — 分析师目标价暗示上行空间 (+3924.4%).
- 分析师共识目标价 $3.30 (+3924.4% 上行空间) — 华尔街分析师认为存在显著上行潜力。
SharesGrow 综合评分： 46/100 其中 3/7 项标准通过。
SharesGrow 7-Criteria Score
✓
价值
100/100
Price-to-Earnings & upside
Proven by this page
✗
健康
25/100
Debt-to-Equity & liquidity
→ Health
估值概览 — AWH
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.30
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.37
每股账面价值$0.00
每股营收$0.27
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
分析师目标价$3.30 (+3924.4%)
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2016 |
$-4.30 |
$2.64M |
$-14.97M |
-566.5% |
| 2017 |
$-2.77 |
$3.12M |
$-10.5M |
-336.3% |
| 2018 |
$-2.43 |
$3.05M |
$-11.37M |
-372.5% |
| 2019 |
$-2.57 |
$4.54M |
$-14.85M |
-327.1% |
| 2020 |
$-2.63 |
$4.65M |
$-17.63M |
-379.1% |
| 2021 |
$-4.28 |
$6.81M |
$-31.71M |
-465.5% |
| 2022 |
$-41.66 |
$8.18M |
$-21.58M |
-263.6% |
| 2023 |
$-1.81 |
$9.15M |
$-16.69M |
-182.3% |
| 2024 |
$-0.93 |
$9.18M |
$-13.09M |
-142.6% |
| 2025 |
$-0.37 |
$9.22M |
$-12.78M |
-138.7% |
